These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8325909)

  • 41. Oncogenes, growth factors, and signal transduction.
    Druker BJ; Mamon HJ; Roberts TM
    N Engl J Med; 1989 Nov; 321(20):1383-91. PubMed ID: 2682241
    [No Abstract]   [Full Text] [Related]  

  • 42. [Oncogenes and tumor suppressor genes in the signal transduction pathways of growth factors].
    Buday L
    Orv Hetil; 1994 Nov; 135(47):2579-84. PubMed ID: 7824256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tyrosine phosphorylation and the regulation of cell growth: growth factor-stimulated tyrosine phosphorylation of phospholipase C.
    Nishibe S; Carpenter G
    Semin Cancer Biol; 1990 Aug; 1(4):285-92. PubMed ID: 2103503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peptide regulatory factors and malignancy.
    Steel CM
    Lancet; 1989 Jul; 2(8653):30-4. PubMed ID: 2567802
    [No Abstract]   [Full Text] [Related]  

  • 45. Growth factors and cancer.
    Aaronson SA
    Science; 1991 Nov; 254(5035):1146-53. PubMed ID: 1659742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered growth regulation in cancer.
    Waterfield MD
    Br Med Bull; 1989 Apr; 45(2):570-81. PubMed ID: 2688817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
    Hernández M; Barrero MJ; Crespo MS; Nieto ML
    J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conditioned tumorigenicity of activated oncogenes.
    Klein G; Klein E
    Cancer Res; 1986 Jul; 46(7):3211-24. PubMed ID: 3011242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenes and cell growth.
    Bos TJ
    Adv Exp Med Biol; 1992; 321():45-9; discussion 51. PubMed ID: 1333167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible regulation of epidermal growth factor-receptor tyrosine autophosphorylation by calcium and G proteins in chemically permeabilized rat UMR106 cells.
    Kawase T; Orikasa M; Oguro A; Burns DM
    Arch Oral Biol; 1999 Feb; 44(2):157-71. PubMed ID: 10206334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenes and tumor suppressor genes.
    Klein G
    Acta Oncol; 1988; 27(4):427-37. PubMed ID: 2849463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EGF stimulates tyrosine phosphorylation of focal adhesion kinase (p125FAK) and paxillin in rat pancreatic acini by a phospholipase C-independent process that depends on phosphatidylinositol 3-kinase, the small GTP-binding protein, p21rho, and the integrity of the actin cytoskeleton.
    Tapia JA; Camello C; Jensen RT; García LJ
    Biochim Biophys Acta; 1999 Jan; 1448(3):486-99. PubMed ID: 9990300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Receptor tyrosine kinase substrates: src homology domains and signal transduction.
    Carpenter G
    FASEB J; 1992 Nov; 6(14):3283-9. PubMed ID: 1385243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integration of G protein signals by extracellular signal-regulated protein kinases in SK-N-MC neuroepithelioma cells.
    Chan AS; Yeung WW; Wong YH
    J Neurochem; 2005 Sep; 94(5):1457-70. PubMed ID: 15992362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.
    Rozakis-Adcock M; McGlade J; Mbamalu G; Pelicci G; Daly R; Li W; Batzer A; Thomas S; Brugge J; Pelicci PG; Schlessinger J; Pawson T
    Nature; 1992 Dec; 360(6405):689-92. PubMed ID: 1465135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oncogenes--"reckless drivers" on signal pathways controlling cell division].
    Johansen T; Bjørkøy G
    Tidsskr Nor Laegeforen; 1998 May; 118(12):1880-5. PubMed ID: 9638058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of G-protein coupled receptors in vascular smooth muscle cells induces tyrosine kinase dependent increases in calcium without tyrosine phosphorylation of phospholipase C gamma-1.
    Di Salvo J; Raatz Nelson S
    FEBS Lett; 1998 Jan; 422(1):85-8. PubMed ID: 9475175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The genetic basis of cancer.
    Tay JS
    J Singapore Paediatr Soc; 1992; 34(3-4):126-35. PubMed ID: 1305651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncogenes, malignant transformation, and modern medicine.
    Miller DM; Blume S; Borst M; Gee J; Polansky D; Ray R; Rodu B; Shrestha K; Snyder R; Thomas S
    Am J Med Sci; 1990 Jul; 300(1):59-69. PubMed ID: 2164772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of transforming G protein-coupled receptors induces rapid tyrosine phosphorylation of cellular proteins, including p125FAK and the p130 v-src substrate.
    Gutkind JS; Robbins KC
    Biochem Biophys Res Commun; 1992 Oct; 188(1):155-61. PubMed ID: 1329743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.